SARANG PHARMA LIMITED Financials
- Company number
- 05262189CopyCopy
- Registered office
- 13 Montpelier Avenue, Bexley, Kent DA5 3AP
- Incorporated
- 18/10/2004
Company snapshot
- Status
- Active
- Employees
- 3 (2025)
- Latest financial data
- 2025
- Accounts type
- Micro Entity
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
-3.73%vs 20242024: £1.38M
Total Assets
-9.27%vs 20242024: £3.06M
Total Liabilities
-13.84%vs 20242024: £1.67M
Employees
0vs 20242024: 3
In 2025, SARANG PHARMA LIMITED reported net assets of £1.33M. The same filing shows total assets of £2.78M and total liabilities of £1.44M. Reported headcount was 3 in 2025. Total Assets fell from £3.06M in 2024 to £2.78M in 2025 (-9.27%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
-3.73%from £1.38M in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures SARANG PHARMA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
-9.4%vs 2023-4.8% a year compound (CAGR)
Total Assets
-19.6%vs 2023-10.3% a year compound (CAGR)
Total Liabilities
-27.2%vs 2023-14.7% a year compound (CAGR)
Employees
0%vs 2023Biggest decrease
Total Liabilities-27.2%
£1.98M in 2023 to £1.44M in 2025
Every measure that changed in SARANG PHARMA LIMITED's filings between 2023 and 2025 fell. The steepest fall came in total liabilities, pointing to lighter outstanding obligations, with net assets and total assets falling alongside it. See the full year-by-year figures.
Ratios from the filed figures
Calculated from SARANG PHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 48.02%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 51.98%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for SARANG PHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Assets£ | 1.58M | 1.47M | 1.38M | 1.33M |
| Total Assets£ | 3.60M | 3.45M | 3.06M | 2.78M |
| Cash in Bank£ | – | – | – | – |
| Total Liabilities£ | 2.02M | 1.98M | 1.67M | 1.44M |
| Employees | 3 | 3 | 3 | 3 |
SARANG PHARMA LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for SARANG PHARMA LIMITED covering 2021–2025, across 4 reported indicators. The most recent reported year is 2025.
SARANG PHARMA LIMITED reported net assets of £1.33M for 2025. That compares with £1.38M in 2024, a change of -3.73%.
SARANG PHARMA LIMITED reported total assets of £2.78M for 2025. That compares with £3.06M in 2024, a change of -9.27%.
SARANG PHARMA LIMITED reported total liabilities of £1.44M for 2025. That compares with £1.67M in 2024, a change of -13.84%.
SARANG PHARMA LIMITED reported 3 employees in 2025, compared with 3 in 2024.
Between 2023 and 2025, SARANG PHARMA LIMITED's net assets fell by 9.4%, total assets fell by 19.6%, total liabilities fell by 27.2% and employee numbers was unchanged. Net assets contracted at 4.8% a year across the two years to 2025, from £1.47M to £1.33M. Reported headcount went from 3 in 2023 to 3 in 2025.
Okredo holds reported figures for the years 2021, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.